Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-05-18 5:24 pm Purchase |
2023-05-17 | 13D | Alimera Sciences, Inc. ALIM |
Caligan Partners LP | 915,057,915,057 9.990% |
915,057,190,341 (+126264245.63%) |
Filing History |
| 2023-04-03 2:24 pm Sale |
2023-03-24 | 13G | Alimera Sciences, Inc. ALIM |
Palo Alto Investors LP | 0 0.000% |
-802,423 (Position Closed) |
Filing History |
| 2023-03-31 11:00 am Purchase |
2023-03-24 | 13D | Alimera Sciences, Inc. ALIM |
Velan Capital Investment Management LP | 749,750 9.990% |
749,750 (New Position) |
Filing History |
| 2023-03-28 5:00 pm Purchase |
2023-03-24 | 13D | Alimera Sciences, Inc. ALIM |
Caligan Partners LP | 724,716 9.990% |
313,189 (+76.10%) |
Filing History |
| 2023-02-14 4:12 pm Unchanged |
2022-12-31 | 13G | Alimera Sciences, Inc. ALIM |
Palo Alto Investors LP | 802,423 11.450% |
0 (Unchanged) |
Filing History |
| 2023-02-08 2:41 pm Purchase |
2022-12-30 | 13G | Alimera Sciences, Inc. ALIM |
MORGAN STANLEY MS |
666,246 9.500% |
102,922 (+18.27%) |
Filing History |
| 2022-10-27 4:23 pm Sale |
2022-02-28 | 13G | Alimera Sciences, Inc. ALIM |
MORGAN STANLEY MS |
563,324 8.100% |
-356,222 (-38.74%) |
Filing History |
| 2022-05-25 5:18 pm Purchase |
2022-05-19 | 13D | Alimera Sciences, Inc. ALIM |
Caligan Partners LP | 411,527 5.900% |
411,527 (New Position) |
Filing History |
| 2022-03-10 4:21 pm Purchase |
2022-02-28 | 13G | Alimera Sciences, Inc. ALIM |
MORGAN STANLEY MS |
919,546 13.300% |
490,000 (+114.07%) |
Filing History |
| 2022-02-14 5:07 pm Purchase |
2021-12-31 | 13G | Alimera Sciences, Inc. ALIM |
Palo Alto Investors LP | 802,423 11.570% |
802,423 (New Position) |
Filing History |
| 2022-02-10 2:33 pm Purchase |
2021-12-31 | 13G | Alimera Sciences, Inc. ALIM |
MORGAN STANLEY MS |
429,546 6.200% |
8,834 (+2.10%) |
Filing History |
| 2022-02-03 4:05 pm Sale |
2022-02-02 | 13G | Alimera Sciences, Inc. ALIM |
HIRSCHMAN ORIN | 0 0.000% |
-501,025 (Position Closed) |
Filing History |
| 2021-04-30 1:16 pm Purchase |
2021-04-16 | 13G | Alimera Sciences, Inc. ALIM |
Ocumension Therapeutics | 1,144,945 16.620% |
1,144,945 (New Position) |
Filing History |
| 2021-02-16 4:20 pm Purchase |
2020-12-31 | 13G | Alimera Sciences, Inc. ALIM |
Palo Alto Investors LP | 802,423 15.640% |
802,423 (New Position) |
Filing History |
| 2021-02-12 12:40 pm Sale |
2020-12-31 | 13G | Alimera Sciences, Inc. ALIM |
Flynn James E | 0 0.000% |
-676,667 (Position Closed) |
Filing History |
| 2021-02-12 08:11 am Sale |
2020-12-31 | 13G | Alimera Sciences, Inc. ALIM |
AVORO CAPITAL ADVISORS LLC | 0 0.000% |
-415,999 (Position Closed) |
Filing History |
| 2021-02-10 4:18 pm Purchase |
2020-12-31 | 13G | Alimera Sciences, Inc. ALIM |
HIRSCHMAN ORIN | 501,025 11.000% |
28,000 (+5.92%) |
Filing History |
| 2021-02-10 11:28 am Sale |
2020-12-31 | 13G | Alimera Sciences, Inc. ALIM |
MORGAN STANLEY MS |
420,712 8.200% |
-26 (-0.01%) |
Filing History |
| 2020-11-09 4:20 pm Purchase |
2020-10-30 | 13G | Alimera Sciences, Inc. ALIM |
MORGAN STANLEY MS |
420,738 8.200% |
420,738 (New Position) |
Filing History |
| 2020-09-29 4:44 pm Purchase |
2020-09-29 | 13D | Alimera Sciences, Inc. ALIM |
Domain Partners VI L.P. | 239,394 4.800% |
239,394 (New Position) |
Filing History |